Foresite Capital Management III as of Dec. 31, 2020
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 8 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Oric Pharmaceuticals | 19.6 | $17M | 497k | 33.85 | |
| Acceleron Pharma | 16.2 | $14M | 109k | 127.94 | |
| Natera (NTRA) | 14.7 | $13M | 127k | 99.52 | |
| Fibrogen (FGEN) | 13.2 | $11M | 306k | 37.09 | |
| Epizyme | 12.6 | $11M | 998k | 10.86 | |
| Aclaris Therapeutics (ACRS) | 12.2 | $11M | 1.6M | 6.47 | |
| Cymabay Therapeutics | 11.0 | $9.4M | 1.6M | 5.74 | |
| Novavax (NVAX) | 0.6 | $558k | 5.0k | 111.60 |
